Document Detail


Thromboatherosclerotic complications in hypertensives: results of the Stockholm Metoprolol (secondary prevention) Trial.
MedLine Citation:
PMID:  3293399     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The outcome of postinfarction patients with a history of hypertension who participated in a randomized, double-blind, secondary prevention study with metoprolol or placebo treatment for 3 years has been evaluated. There were 41 patients in the placebo group and 35 patients in the metoprolol group. Elevated blood pressure was treated primarily by the addition of thiazide diuretics. Blood pressures were nearly identical in the two treatment groups. During the 3 years, 11 patients died in the placebo group and seven died in the metoprolol group. Occurrence of nonfatal events was also higher in the placebo than in the treated group: 12 patients vs one patient for reinfarction (p less than 0.005), three patients vs no patients for coronary artery bypass grafting, four patients vs no patients for cerebrovascular events, and one patient vs no patients for lower limb amputation. The total number of patients with any event was 24 vs eight (p less than 0.01). The present results may imply that treatment after infarction with metoprolol reduces nonfatal thromboatherosclerotic complications, especially nonfatal reinfarctions, in patients with a history of hypertension. However, inasmuch as the results were obtained from a retrospective subgroup analysis, they must be interpreted with caution.
Authors:
G Olsson
Related Documents :
1211029 - Risk factors in peripheral arterial disease. an out-patient pilot study at the departme...
10793049 - Nicardipine is a safe and effective agent in pediatric hypertensive emergencies.
14597859 - High rate of detection of primary aldosteronism, including surgically treatable forms, ...
2142489 - Improved results with surgical treatment of renovascular hypertension: an individualize...
21157949 - Incidence of gastric involvement in patients with nongastrointestinal extranodal margin...
2715369 - Transdermal clonidine compared with hydrochlorothiazide as monotherapy in elderly hyper...
10986209 - Perceptual responses in patients with inflammatory and functional bowel disease.
3898689 - Aminoglutethimide and metyrapone in the management of cushing's syndrome.
19789219 - Bronchial measurements in patients with asthma: comparison of quantitative thin-section...
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  American heart journal     Volume:  116     ISSN:  0002-8703     ISO Abbreviation:  Am. Heart J.     Publication Date:  1988 Jul 
Date Detail:
Created Date:  1988-08-12     Completed Date:  1988-08-12     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0370465     Medline TA:  Am Heart J     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  334-8     Citation Subset:  AIM; IM    
Affiliation:
Department of Medicine, Karolinska Institutet, Danderyd Hospital, Sweden.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Arteriosclerosis / epidemiology*,  etiology,  mortality
Cause of Death
Clinical Trials as Topic
Double-Blind Method
Humans
Hypertension / complications*,  drug therapy,  mortality
Metoprolol / therapeutic use*
Myocardial Infarction / complications
Prospective Studies
Random Allocation
Sweden
Thrombosis / epidemiology*,  etiology,  mortality
Time Factors
Chemical
Reg. No./Substance:
37350-58-6/Metoprolol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Overview: hypertension and atherosclerosis.
Next Document:  Primary prevention in patients with hypertension: comments on the clinical implications of the MAPHY...